SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2994Bortezomib in Combination with Conventional Chemotherapeutic Agents for MultipleIcebrg-12/26/2007
2993MORGAN STANLEY DOWNS MLNM..AS OVERVALUED! 21-Dec-07 09:17 am Stock OveIcebrg-12/22/2007
2992Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatmtnsaf-12/21/2007
2991Phase I Study of Two Different Schedules of Bortezomib and Pemetrexed in AdvanceIcebrg-12/20/2007
2990FBR Bullish on Millennium Pharma in 2008 Tuesday December 18, 2:25 pm ET MillennIcebrg-12/18/2007
2989Third Rock Hires Three Partners—Says Team Complete to Implement Its Hands-On, EaIcebrg-12/17/2007
2988Erik; <i>n addition, Levin may not be too happy to see, that Dunsire runsSteve Lokness-12/16/2007
2987>>What do you take from this? Might give MLNM first shot at upstart biotecIcebrg-12/16/2007
2986<i>Third Rock now lists nine partners, six of whom are former Millennium eSteve Lokness-12/15/2007
2985Third Rock taps three biotech vets as partners Mass High Tech: The Journal of NeIcebrg-12/15/2007
2984[Boronate on the Yahoo board sums up his impressions after this year's ASH.]Icebrg-12/15/2007
2983"Bolje vrabac u ruci nego golub na grani!"Miljenko Zuanic-12/13/2007
2982Charles Homcy, Director, exercised an option to buy 59.238 shares @ 6,49 and immIcebrg-12/13/2007
2981Data May Help Cancer Drug Gain Approval for Wider Use By RACHEL ZIMMERMAN DecemDoc Bones-12/11/2007
2980Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III FIcebrg-12/10/2007
2979Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic FourfolIcebrg-12/10/2007
2978AVE1642 Clinical Findings Reported AVE1642 is a “naked” (non-conjugated) antiboIcebrg-12/8/2007
2977Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin [plus bortezomib], Icebrg-12/8/2007
2976Bortezomib in combination with celecoxib in patients with advanced solid tumors:Icebrg-12/8/2007
2975CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective phaIcebrg-12/8/2007
2974Wachovia Starts Millennium Pharmaceuticals (MLNM) at Market Perform 12-03-2007 0Icebrg-12/4/2007
2973Millennium drops arthritis drug after fails trial Wed Nov 28, 2007 2:27pm EST BIcebrg-11/28/2007
2972[The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by tuck-11/28/2007
2971 >> Haematologica. 2007 Oct;92(10):1351-8. Links Treatment of light chaintuck-11/27/2007
2970Millennium Pharmaceuticals "outperform," target price raised Monday, Icebrg-11/27/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News